# Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Canonical URL: https://biopharmsignal.com/news/ABSI/absci-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4
Ticker: ABSI
Company: Absci Corporation
Source: Absci Corporation
Published: 2026-05-05 00:12 EST
Original Source URL: https://investors.absci.com
## Summary

VANCOUVER, Wash. and NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced that on May 1, 2026, the company granted a non-statutory stock option to

## Article Body
VANCOUVER, Wash. and NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced that on May 1, 2026, the company granted a non-statutory stock option to
## Recent Company News
- 2026-05-07 20:06 EST — [Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results](https://biopharmsignal.com/news/ABSI/absci-reports-business-updates-and-first-quarter-2026-financial-and-operating-results) — Source: Absci Corporation
- 2026-05-05 00:12 EST — [Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ABSI/absci-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4) — Source: Absci Corporation
- 2026-04-23 20:04 EST — [Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026](https://biopharmsignal.com/news/ABSI/absci-to-report-business-updates-and-first-quarter-2026-financial-and-operating-results-on-may-7-2026) — Source: Absci Corporation
- 2026-04-08 12:00 EST — [Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/ABSI/absci-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference) — Source: Absci Corporation
- 2026-03-24 20:05 EST — [Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results](https://biopharmsignal.com/news/ABSI/absci-reports-business-updates-and-fourth-quarter-and-full-year-2025-financial-and-operating-results) — Source: Absci Corporation
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)